• Produktbild: Cancer Drug Resistance
  • Produktbild: Cancer Drug Resistance

Cancer Drug Resistance Methods and Protocols

Fr. 171.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

23.07.2023

Herausgeber

Marta Baiocchi

Verlag

Springer Us

Seitenzahl

242

Maße (L/B/H)

25.4/17.8/1.5 cm

Gewicht

489 g

Auflage

1st ed. 2022

Sprache

Englisch

ISBN

978-1-07-162515-6

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

23.07.2023

Herausgeber

Marta Baiocchi

Verlag

Springer Us

Seitenzahl

242

Maße (L/B/H)

25.4/17.8/1.5 cm

Gewicht

489 g

Auflage

1st ed. 2022

Sprache

Englisch

ISBN

978-1-07-162515-6

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Cancer Drug Resistance
  • Produktbild: Cancer Drug Resistance
  • A 3D Biomimetic System for Testing Anticancer Drugs Sensitivity.- Patient-Derived Breast Cancer Tissue Cultures for Anti-Endocrine Drug Assays.- Co-Culture of Two Different Cell Lines in a Two-Layer Microfluidic Device.- Generation and Culture of Organotypic Breast Carcinoma Spheroids for the Study of Drug Response in a 3D Microfluidic Device.- A Methodological Workflow to Analyze Synthetic Lethality and Drug Synergism in Cancer Cells.- Establishment of In Vivo Acquired Resistance to Chemotherapy via Individual Dose Escalation Treatment Regime.- A Label Retaining System to Capture Slow Cycling Cancer Cells.- A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance.- Assessment of Tumor Heterogeneity in High-Grade Serous Ovarian Cancer: Mass Cytometry to Understand the Complex Tumor Biology.- Analysis of Transcriptomic Data Generated from Drug Treated Cancer Cell Line.- Simultaneous Mapping of Enhancers and Enhancer Rearrangements with Paired-End H3K27ac ChIP-seq.- Identification of Drug Resistance Mechanisms using Genome-Wide CRISPR-Cas9 Screens.- RNA Sequencing Data Analysis on the Maser Platform and the Tag-Count Comparison-Graphical User Interface.- Dissecting the Epigenomic Driving Drug Resistance by ATAC-Seq.- Polygenomic Interrogation of Drug Resistance Genes.- Analysis of ER-phagy in Cancer Drug Resistance.- Drug Target Prediction using Context-Specific Metabolic Models Reconstructed from rFastcormics.